Segment Information - Operating Results by Reportable Segment (Detail) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 30, 2016 |
Jun. 30, 2015 |
Jun. 30, 2016 |
Jun. 30, 2015 |
Dec. 31, 2015 |
|
| Segment Reporting Information [Line Items] | |||||
| Net Revenue | $ 2,230 | $ 0 | $ 2,890 | $ 500 | |
| Direct cost of goods | 324 | 0 | 324 | 0 | |
| Sales and marketing costs | (1,998) | (727) | (3,884) | (1,300) | |
| Research and development | 6,347 | 2,411 | 14,100 | 4,066 | |
| General and administrative | 8,635 | 3,803 | 16,550 | 7,280 | |
| Segment loss from operations | (15,136) | (7,762) | (30,227) | (19,833) | |
| Segment assets | 98,062 | 83,699 | 98,062 | 83,699 | $ 118,610 |
| Dermatology Product Sales [Member] | |||||
| Segment Reporting Information [Line Items] | |||||
| Net Revenue | 982 | 0 | 1,364 | 0 | |
| Direct cost of goods | (324) | 0 | (324) | 0 | |
| Sales and marketing costs | (1,998) | (727) | (3,884) | (1,300) | |
| Research and development | 0 | 0 | 0 | 0 | |
| General and administrative | 0 | 0 | 0 | 0 | |
| Segment loss from operations | (1,340) | (727) | (2,844) | (1,300) | |
| Segment assets | 3,058 | 1,569 | 3,058 | 1,569 | |
| Pharmaceutical and Biotechnology Product Development [Member] | |||||
| Segment Reporting Information [Line Items] | |||||
| Net Revenue | 1,248 | 0 | 1,526 | 500 | |
| Direct cost of goods | 0 | 0 | 0 | 0 | |
| Sales and marketing costs | 0 | 0 | 0 | ||
| Research and development | (8,407) | (3,959) | (16,244) | (13,053) | |
| General and administrative | (6,637) | (3,076) | (12,665) | (5,980) | |
| Segment loss from operations | (13,796) | (7,035) | (27,383) | (18,533) | |
| Segment assets | $ 95,004 | $ 82,130 | $ 95,004 | $ 82,130 | |
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|